Novel predictive tools for Irish radical prostatectomy pathological outcomes: Development and validation

Irish Journal of Medical Science

Volumn 179, Issue 2, 2010, Pages 187-195

  Fanning, D M ^a   Yue, F ^a   Fitzpatrick, J M ^b   Watson, R W G ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Nomogram; Prognosis; Prostate cancer; Prostatectomy; Tumour staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; GLEASON SCORE; HUMAN; IRELAND; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SEMINAL VESICLE; TUMOR BIOPSY; VALIDATION PROCESS; AREA UNDER THE CURVE; CANCER STAGING; CONFIDENCE INTERVAL; HEALTH STATUS INDICATOR; MIDDLE AGED; NOMOGRAM; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; PROSTATIC NEOPLASMS; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VALIDATION STUDY;

ADULT; AGED; AREA UNDER CURVE; CONFIDENCE INTERVALS; HEALTH STATUS INDICATORS; HUMANS; IRELAND; MALE; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 77954423241     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-009-0393-6     Document Type: Article

References (31)

1. J Ferlay P Autier M Boniol M Heanue M Colombet P Boyle 2007 Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 3 581 592 10.1093/annonc/mdl498 10.1093/annonc/mdl498 1:STN:280:DC%2BD2s7hslSgtw%3D%3D 17287242 (Pubitemid 46359643)
2. Trends in Irish cancer incidence 1994-2002 with projections to 2020. June 2006, National Cancer Registry Ireland
3. P O'Lorcain H Comber 2007 Prostate cancer mortality predictions for Ireland up to 2015 Eur J Cancer Prev 16 4 328 333 10.1097/01.cej.0000236248. 63489.4c 10.1097/01.cej.0000236248.63489.4c 17554205 (Pubitemid 47165298)
4. DV Makarov BJ Trock EB Humphreys LA Mangold PC Walsh JI Epstein AW Partin 2007 Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin Tables) based on cases from 2000 to 2005 Urology 69 6 1095 1101 10.1016/j.urology.2007.03.042 10.1016/j.urology.2007.03.042 17572194 (Pubitemid 46891611)
5. A Gallina FK Chun A Briganti SF Shariat F Montorsi A Salonia A Erbersdobler P Rigatti L Valiquette H Huland M Graefen PI Karakiewicz 2007 Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy Eur Urol 52 1 98 105 10.1016/j.eururo.2007.01.060 10.1016/j.eururo.2007.01.060 17267098 (Pubitemid 46803017)
6. JA Eastham PT Scardino MW Kattan 2008 Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram J Urol 179 6 2207 2210 10.1016/j.juro.2008.01.106 10.1016/j.juro.2008.01.106 18423693
7. FK Chun PT Scardino A Erbersdobler E Currlin J Walz T Schlomm A Haese H Heinzer M McCormack H Huland M Graefen PI Karakiewicz 2006 Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology Eur Urol 49 5 820 826 10.1016/j.eururo.2005.11.007 10.1016/j.eururo.2005.11.007 16439050
8. SF Shariat PI Karakiewicz V Margulis MW Kattan 2008 Inventory of prostate cancer predictive tools Curr Opin Urol 18 3 279 296 10.1097/MOU. 0b013e3282f9b3e5 10.1097/MOU.0b013e3282f9b3e5 18382238 (Pubitemid 351489379)
9. SF Shariat PI Karakiewicz CG Roehrborn MW Kattan 2008 An updated catalog of prostate cancer predictive tools Cancer 113 11 3075 3099 10.1002/cncr.23908 10.1002/cncr.23908 18823041
10. AW Partin J Yoo HB Carter JD Pearson DW Chan JI Epstein PC Walsh 1993 The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1 110 114 1:STN:280:DyaK3s3oslaktA%3D%3D 7685418 (Pubitemid 23175983)
11. AW Partin MW Kattan EN Subong PC Walsh KJ Wojno JE Oesterling PT Scardino JD Pearson 1997 Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update JAMA 277 18 1445 1451 10.1001/jama.277.18.1445 10.1001/jama.277.18.1445 1:STN:280:DyaK2s3ptFWjsA%3D%3D 9145716
12. AW Partin LA Mangold DM Lamm PC Walsh JI Epstein JD Pearson 2001 Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium Urology 58 6 843 848 10.1016/S0090-4295(01)01441-8 10.1016/S0090-4295(01)01441-8 1:STN:280:DC%2BD3MnpvV2htg%3D%3D 11744442 (Pubitemid 34017254)
13. JM Taylor DP Ankerst RR Andridge 2008 Validation of biomarker-based risk prediction models Clin Cancer Res 14 19 5977 5983 10.1158/1078-0432.CCR-07-4534 10.1158/1078-0432.CCR-07-4534 18829476
14. N Bhojani S Ahyai M Graefen U Capitanio N Suardi SF Shariat C Jeldres A Erbersdobler T Schlomm A Haese T Steuber H Heinzer F Montorsi H Huland PI Karakiewicz 2009 Partin Tables cannot accurately predict the pathological stage at radical prostatectomy Eur J Surg Oncol 35 2 123 128 10.1016/j.ejso.2008.07. 013 1:STN:280:DC%2BD1M%2FnslWnug%3D%3D 18786800
15. N Bhojani L Salomon U Capitanio N Suardi SF Shariat C Jeldres L Zini D Pharand F Péloquin P Arjane CC Abbou A De La Taille F Montorsi PI Karakiewicz 2009 External validation of the updated Partin Tables in a cohort of French and Italian men Int J Radiat Oncol Biol Phys 73 2 347 352 10.1016/j.ijrobp.2008.04.082 19004573
16. DF Gleason 1966 Classification of prostatic carcinomas Cancer Chemother Rep 50 3 125 128 1:STN:280:DyaF287ht1WgsA%3D%3D 5948714
17. KC Zorn A Gallina GC Hutterer J Walz AL Shalhav GP Zagaja L Valiquette ON Gofrit MA Orvieto JB Taxy PI Karakiewicz 2007 External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy J Endourol 21 11 1345 1351 10.1089/end.2007.0044 10.1089/end.2007.0044 18042028 (Pubitemid 350191386)
18. A Briganti A Gallina N Suardi FK Chun J Walz R Heuer A Salonia A Haese P Perrotte L Valiquette M Graefen P Rigatti F Montorsi H Huland PI Karakiewicz 2008 A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer BJU Int 101 5 556 560 10.1111/j.1464-410X.2007. 07321.x 10.1111/j.1464-410X.2007.07321.x 18005204 (Pubitemid 351199277)
19. Quinlan DM, Partin AW, Walsh PC (1995) Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment? Urology 46(3)(Suppl A):77-82. doi: 10.1016/S0090-4295(99)80254-4
20. C Gosselaar R Kranse MJ Roobol S Roemeling FH Schröder 2008 The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer Prostate 68 9 985 993 10.1002/pros.20759 10.1002/pros.20759 1:STN:280:DC%2BD1czivVentw%3D%3D 18409186 (Pubitemid 351794163)
21. JM Fitzpatrick E Banu S Oudard 2009 Prostate-specific antigen kinetics in localized and advanced prostate cancer BJU Int 103 5 578 587 10.1111/j.1464-410X.2009.08345.x 10.1111/j.1464-410X.2009.08345.x 19210674
22. CR King 2000 Patterns of prostate cancer biopsy grading: trends and clinical implications Int J Cancer 90 6 305 311 10.1002/1097-0215(20001220)90: 6<305::AID-IJC1>3.0.CO;2-U 10.1002/1097-0215(20001220)90:6<305::AID- IJC1>3.0.CO;2-U 1:STN:280:DC%2BD3M7jvFentA%3D%3D 11180133 (Pubitemid 32049292)
23. PI Karakiewicz N Bhojani U Capitanio AM Reuther N Suardi C Jeldres D Pharand F Péloquin P Perrotte SF Shariat EA Klein 2008 External validation of the updated Partin Tables in a cohort of North American men J Urol 180 3 898 902 10.1016/j.juro.2008.05.044 10.1016/j.juro.2008.05.044 18635222
24. ML Blute EJ Bergstralh AW Partin PC Walsh MW Kattan PT Scardino JE Montie JD Pearson JM Slezak H Zincke 2000 Validation of Partin Tables for predicting pathological stage of clinically localized prostate cancer J Urol 164 5 1591 1595 10.1016/S0022-5347(05)67035-8 10.1016/S0022-5347(05)67035-8 1:STN:280:DC%2BD3M%2FjtFGqtA%3D%3D 11025711
25. EI Heath MW Kattan IJ Powell W Sakr TC Brand BA Rybicki IM Thompson WJ Aronson MK Terris CJ Kane JC Presti Jr CL Amling SJ Freedland 2008 The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer Urology 71 1 151 155 10.1016/j.urology.2007.08.016 10.1016/j.urology.2007.08.016 18242385 (Pubitemid 351173254)
26. R Ayyathurai K Ananthakrishnan R Rajasundaram RJ Knight H Toussi V Srinivasan 2006 Predictive ability of Partin Tables 2001 in a Welsh population Urol Int 76 3 217 222 10.1159/000091622 10.1159/000091622 16601382
27. X Gao S Ren X Lu C Xu Y Sun 2008 The newer the better? Comparison of the 1997 and 2001 Partin Tables for pathologic stage prediction of prostate cancer in China Urology 72 5 1096 1101 10.1016/j.urology.2008.07.047 10.1016/j.urology.2008.07.047 18822453
28. S Naito K Kuroiwa N Kinukawa K Goto H Koga O Ogawa M Murai T Shiraishi Clinicopathological Research Group for Localized Prostate Cancer Investigators 2008 Validation of Partin Tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer J Urol 180 3 904 909 10.1016/j.juro.2008.05.047 10.1016/j.juro.2008.05.047 1:CAS:528:DC%2BD1cXhtVKmsbjO 18635221
29. FJ Drummond AE Carsin L Sharp H Comber 2009 Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners BMC Fam Pract 12 10 3 10.1186/1471-2296-10-3 10.1186/1471-2296-10-3
30. CH Lim DM Quinlan 2007 Are doctors examining prostates in university hospital? Urology 70 5 843 845 10.1016/j.urology.2007.07.010 10.1016/j.urology.2007.07.010 18068436 (Pubitemid 350192585)
31. MR Quinlan S Teahan D Mulvin DM Quinlan 2007 Is digital rectal examination still necessary in the early detection of prostate cancer? Ir J Med Sci 176 3 161 163 10.1007/s11845-007-0018-x 10.1007/s11845-007-0018-x 1:STN:280:DC%2BD2sjktFehug%3D%3D 17786503 (Pubitemid 47377511)